Interesting that Androxal is actually being marketed as a treatment for male hypogonadism. This would be good news for us in Canada because other drugs are for use in women only and are considered "off label" for men, and therefore are not used here.
I just found this info FYI:
THE WOODLANDS, Texas, June 8, 2015 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc.(Nasdaq:RPRX) today announced that the Division of Bone, Reproductive and Urologic Products of the U.S. Food and Drug Administration (FDA) has scheduled the advisory committee to review the Company's New Drug Application (NDA) for its enclomiphene product candidate, formerly known as Androxal, on November 3, 2015. The Company submitted the NDA on January 30, 2015. The FDA accepted the NDA for review on April 1, 2015 and later assigned a Prescription Drug User Fee Act (PDUFA) goal date of November 30, 2015.